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This study was carried out in order to compare the effects
in different surgeries using mesh in pelvic organ prolapse
patients whose leading points were C. Thirty-nine patients
were categorized into 3 groups: group A pelvic reconstruction
with hysterectomy; group B hysterectomy prior to pelvic
reconstruction; and group C pelvic reconstruction with uterus
preserved. At first visit, POP-Q stage was determined, and age,
BMI, admission days, operation time, post-operative stage and
complications were observed and results were analyzed and
compared. All patients who were operated upon converted to
stage one month following the operation, and no further
change was observed except in one patient. Group admission
days were not significantly different, but tended to be lower
in group C. Group average operation times between ‘group A
and B’ and ‘group A and C’ were statistically different. No
significant difference was observed in post-operative complica-
tions between the groups, but 3 members of group A devel-
oped erosion, whereas no erosion occurred in groups B and
C. Pelvic reconstruction using mesh is a highly efficient
method of treating pelvic organ prolapse. Improvements in
stage and post-operative complications were not significantly
different in the groups. However, uteropexy showed a shorter
operation time, fewer admission days, and less erosion due to
mesh than conventional pelvic reconstruction with hysterec-
tomy.
Key Words: Pelvic organ prolapse, pelvic reconstruction,
mesh
INTRODUCTION
Pelvic organ prolapse is a prolapsed state of
intrapelvic organs such as uterus, bladder, rectum
and some digestive organs due to damaged in-
trapelvic organ supporting tissue at a defective
site of the vaginal wall. Pelvic organ prolapse is
caused by dysfunction of the fibromuscular tissue
that localizes the pelvic structure in the pelvic
cavity.1 In view of the proximities of female geni-
tals, lower urinary tract, and lower digestive sys-
tem, it is can be presumed that the pelvic organ
prolapse can affect the functions of the bladder,
urinary tract and rectum. Morevere pelvic organ
prolapse causes not only cause urinary incon-
tinence, but is also related to urinary track occlu-
sion and bowel disorders that may induce recur-
rent urinary tract infections, rectocele, hydrone-
phrosis, or urinary disturbance.2
In view of a report3 that pelvic organ prolapse,
which is associated with quality of life rather than
being directly associated with life itself, occurs
more frequently on aging and at the time of
menopause, and in about 50% of women with a
delivery history, it is an important gynecological
problem in aged women. Moreover, an effective
treatment for pelvic organ prolapse becomes more
necessary given the extended average life span,
and provides a more active social life for women,
it also substantially enhances the quality of life.
Olsen et al.4 reported that the causes of pelvic
organ prolapse are aging, menopause, delivery
history, obesity, smoking history, and chronic pul-
monary disease. Kim5 reported that pelvic organ
prolapse is caused by various factors that induce
the weakening of the supporting functions of the
fundus pelvis, such as, genetic factors, gynecologi-
cal surgery history, vaginal delivery, neurological
damage, smoking, obesity, internal factors,, and
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internal defects of the urethral sphincter. In addi-
tion, Parker et al.6 indicated the genetic collagen-
ous tissue disease is one of the important latent
causes of t prolapse, having found that pelvic
organ prolapse shows different frequencies by
races and family history, and that is commonly
coexists with hiatal hernia and abdominal striae.
According to a report by Olsen et al., 1 in 11
American women need surgery for pelvic organ
prolapse before the age of 80 years, and 30% of
women operated upon need reoperation due to
prolapse recurrence.4 Moreover, the frequency of
pelvic organ prolapse after hysterectomy was
reported to be 0.2 - 1% by Cruikshank and Cox in
1990,7 Lefranc et al. reported frequency 18.2% in
2002 and stated that pelvic organ prolapse is
associated with bladder prolapse or rectocele.8 In
view of fact that most women with pelvic pro-
lapse undergo only preservative treatment, or do
not receive any treatment, then more women will
probably experience prolapse. Since the pelvic
urethral bladder sling operation was perfomed by
Marshall et al. in 1949, many pelvic reconstruction
surgery methods have been developed. However,
an unacceptable number of cases require retreat-
ment due to a high rates of postoperative recur-
rence.9
Mesh has been used in abdominal prolapse
correcting surgeries in our department of general
surgery for a some time, and is now used to fix
pelvic organs to the posterior pelvic cavity in
pelvic organ prolapse and urinary incontinence
surgeries. It is also used in the urethral slings and
in similar surgical modalities in gynecology field.
However, the use of mesh, an alien substance,
can cause dysuria, erosion in the lower urinary
tract, vagina, or abdominal tissue, and can induce
synechia in the intestines leading to intestinal
occlusion.9,10 Accordingly, the ideal mesh should
be bio-compatible and endurable, to maintain
steady tension, but should not cause allergic reac-
tions or induce infection. Mesh should also be
aseptic, non-carcinogenetic, strong enough to be
endure mechanical impact, it should also be
readily available and corrosion resistant.
9
Never-
theless, we lack the objective information on the
side effects of using mesh.
Current topics of discussion in pelvic recon-
struction surgery using the mesh are, should the
uterus be resected,2 and should a healthy organ be
eliminated or not due to an uterine disease.
However, no study has compare the postoperative
effects and complications of pelvic reconstruction
using mesh between in performing together with
hysterectomy and in preserving the uterus. There-
fore, we designed this study to investigate pa-
tients with pelvic organ prolapse, a leading point
C, who underwent pelvic reconstruction using
mesh, and compared the results in cases that un-
derwent pelvic reconstruction together with hys-
terectomy, hysterectomy prior to pelvic recon-
struction, or only uteropexy with uterus preserva-
tion.
MATERIALS AND METHODS
We conducted retrospective analysis on a 39
patients with a chief complaint of pelvic organ
prolapse who were admitted to the Department of
Gynecology and Obstetrics at Yonsei University
Severance Hospital and who underwent pelvic
reconstruction using mesh between March 1, 1999
and May 2002, and who were followed-up for
more than 1 year. This study was approved by the
hospital's institutional review board.
Patients were categorized into 3 groups. Group
A underwent hysterectomy and pelvic reconstruc-
tion together; Group B underwent hysterectomy
prior to pelvic reconstruction; and Group C un-
derwent only pelvic reconstruction with uterus
preservation. We performed whole hysterectomy,
pexis through abdomen, sacrum and vagina,
vaginal wall surrounding revision, colpoplasty,
suprapubic cystotomy and cytoscopy on group A;
pexis through abdomen, sacrum and vagina,
vaginal wall surrounding revision, colpoplasty,
suprapubic cystotomy and cytoscopy on group B;
and uteropexy, vaginal wall surrounding revision,
colpoplasty, suprapubic cystotomy and cytoscopy
on group C.
The POP-Q stage of each patient was deter-
mined by a conducting thorough physical exami-
nation and by confirming medical history, age,
delivery history, body mass index (BMI), meno-
pause state, and abnormal urinogenital symptoms
at the first hospital visit,11 Admission days, opera-
tion times and postoperative acute hemorrhage
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levels were observed during hospitalization.
Patients were interviewed at an outpatient clinic
for the postoperative POP-Q disease stage change,
complications, and urogynecologic problems 1, 3,
6, 9, and 12 months after release from hospital.
The Kruskal-Wallis test was used to compare
ages, delivery histoies, BMIs, admission days,
operation times and hemoglobin concentration
changes. Fisher's exact test was used to compare
preoperative urogynecologic symptoms and pel-
vic prolapse stage. The level of significance was
set at p < 0.05.
RESULTS
Of 39 study subjects, 19 patients belonged to
group A, and group B and C contained 10 patients
each. Patient's age, delivery history and BMI dis-
tribution was not statistically significant between
groups, and neither was the existence or absence
of the preoperative urogynecologic disease. Many
patients in group A were in stage IV. All patients
excluding 1 case in group C were in menopause
(Table 1).
Group admission days were not significantly
different, but were shorter in group C. The mean
operation time was significantly longer in group
A. Hemoglobin concentrations at the 1st post-
operative day was not significantly different form
preoperative values.
As for postoperative acute complications, post-
operative fever was observed in total 11 of the 39
cases, and group A showed this complication
most in 8 cases. In addition, transfusion due to
postoperative hemorrhage was conducted in 10
cases, and urination promoter (cholinergic medi-
cation and alpha receptor blocker) was used in 19
cases with postoperative dysuria. In addition,
second abdominal suturing was performed in 3
cases because of the dehiscence. Intestinal obstruc-
tion occurred in 2 cases and 1 case showing cys-
titis symptoms and was readmitted to hospital for
treatment. However, no cases of phlebothrom-
bosis or pulmonary artery embolism occurred,
which are generally found postoperatively (Table
2).
All of the 21 (54%) patients in stage IV became
stage 0 during the 1st postoperative month. Of
these, 1 (5%) case was stage II at the 3rd post-
operative month and this stage was subsequently
for 1 year. All 17 (44%) cases in preoperative stage
III, and 1 (2%) case in preoperative stage II
achieved stage 0 at the 1st postoperative month,
and all were maintained though the 1-year follow-
up (Table 3).
Postoperative urologic complications were, con-
stipation in 6 (15%) cases after 1 postoperative
month, detrusor instability in 4 (10%) cases, ur-
gent urination in 3 (8%) cases, and frequent urina-
tion in 2 (5%) cases. There were not significantly
different but were most common in group A. At
the 3-month postoperative follow-up cases in
Table 1. General Characteristics of Operation Patients
A (n=19) B (n=10) C (n=10) Chi-square (p-value)
Age (yrs) 66 (59 - 85)* 63 (59 - 81) 65 (33 - 78) 1.06 (0.588)
Parity 4 (1 - 7) 4 (2 - 7) 4 (2 - 8) 0.47 (0.792)
BMI (kg/m2) 23.4 (17.8 - 31.0) 23.0 (19.4 - 28.1) 23.6 (17.6 - 29.1) 0.68 (0.712)
Urologic Sx 15/19 9/10 8/10 0.58 (0.872)
Preoperative stage 12.04 (0.008)
2 0 (0.0%) 0 (0.0%) 1 (100.0%)
3 4 (23.5%) 6 (35.3%) 7 (41.2%)
4 15 (71.4%) 4 (19.0%) 2 (9.5%)
*median (interval).
Kruskal-Wallis test.
Fisher’s exact test.
Table 3. The Change of POP Stage (n=39)
Stage Preop 1 months 3 months 6 months 12 months
Group A
(n=19)
0 19 18 18 18
I
II 1 1 1
III 4
IV 15
Group B
(n=10)
0 10 10 10 10
I
II
III 6
IV 4
Group C
(n=10)
0 10 10 10 10
I
II 1
III 7
IV 2
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Table 2. Results of Operation
A* (n=19) B (n=10) C (n=10) Chi-square (p-value)
Admission day (days) 12 (9 - 60)§ 12 (8 - 21) 11 (8 - 14) 2.63 (2.268)
Op time (min) 220 (180 - 250) 175 (130 - 210) 180 (170 - 240) 17.64 (0.0001)
Hb loss (mg/dl) 1.7 (0 - 5) 2.65 (-0.5 - 3.7) 2.5 (1.8 - 3.6) 2.07 (0.35)
Acute complication
Fever 8 2 1
Transfusion 5 3 3
2 closure 2 1 0
Re-admission 1 0 0
Ileus 0 1 1
UTI 1 0 0
Urethral dilatation 0 0 1
*TAH, Abdomino-sacral colpopexy with mesh, Paravaginal repair, A-P repair, Burch colposuspension, Suprapubic cystostomy,
Cystoscopy.
Abdomin-sacral colpopexy with mesh, Paravaginal repair, Burch colposuspension, P-repair, Suprapubic cystostomy, Cystoscopy.
Abdomino-sacral uteropexy with mesh, Paravaginal repair, P-repair, Burch colposuspension. Suprapubic cystostomy, Cystoscopy.
§
median(interval).
Kruskal-Wallis test.
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group A showed the vaginal erosion, constipation,
frequent urination, and urinary incontinence. In
the subsequent follow-up, frequent urination, in-
continence, and vaginal erosion were continu-
ously observed, but these symptoms and fre-
quencies reduced with time (Table 4). No recur-
rence occurred during the follow-up period.
DISCUSSION
The pelvic organ prolapse is a state whereby
the uterus, bladder, or and some digestive organ
is prolapsed from its normal anatomical location
due to a defect in the intrapelvic organ sup-
porting structure. Pelvic reconstruction is con-
ducted to maintain urination and defecation con-
tinence and to allow sexual functioning by pre-
serving the vagina by correcting those anatomical
defects caused by pelvic organ prolapse.10,12
Generally, the most important causes of pelvic
organ prolapse are related to damage caused
during vaginal delivery or by hysterectomy.
Vaginal delivery may damage nerves distributed
in the pelvic fundus muscle due to direct pelvic
muscle damage by the infant head, and second-
arily may induce pelvic myoatrophy.12 Pelvic sur-
geries like hysterectomy cause not only anatomi-
cal deformation but also neuro- and hemo-circu-
latory disorders that may generate pelvic myo-
atrophy.13
The principal treatment for pelvic organ pro-
lapse is surgical correction if there is no contrain-
dication to anesthesia or surgery. Preservative
therapy using pessary is used in cases with sur-
gical problems caused by accompanying internal
disease or an advanced age, which increase surgi-
cal risk, or in those who do not feel comfortable
Table 4. Postoperative Complication
A(n=19) B (n=10) C (n=10)
1 month later
Constipation 4 (21%) 1 (10%) 1 (10%)
Detrussor instability 2 (11%) 1 (10%) 1 (10%)
Urgency 1 (5%) 2 (20%)
Frequency 1 (5%) 1 (10%)
3 month later
Vaginal erosion 3 (16%)
Urgency 2 (11%)
Constipation 1 (5%) 1 (10%)
Frequency 1 (5%) 1 (10%)
Urinary incontinence 1 (5%) 1 (10%)
6 month later
Vaginal erosion 3 (16%)
Frequency 1 (5%)
Urinary incontinence 2 (11%) 2 (20%)
12 month later
Vaginal erosion 3 (16%)
Frequency 2 (11%) 1 (10%)
Urinary incontinence 1 (5%) 1 (10%)
Comparison of the Effects of Different Surgeries Using Mesh in Pelvic Organ Prolapse Patients 117
Yonsei Med J Vol. 46, No. 1, 2005
about surgery.14,15 However, despite its recent
common use and its advantages laparoscopy is
unstandardized as yet.16
Pelvic reconstruction using mesh is a highly
effective method of the pelvic organ prolapse
treatment because its shortens operation time,
reduces viral infection, and decreases intravaginal
cavity damage during the operation, thus in-
creasing the likelihood of a postoperative sexual
life.9 According to a retrospective study by
Valaitis et al., the curative rate of pelvic recon-
struction using mesh is 88%, 17 and Costantini et
al. reported that over 90% of the patients were
satisfied with surgery.2 In the present study, all
patients achieved stage changes from IV to 0,
exclusive of 1 case that achieved stage II, during
the follow-up. Moreover, all urogynecologic dis-
eases including urinary incontinence, complained
of before surgery were improved. Adverse reac-
tions after pelvic reconstruction using mesh in-
clude, intestinal occlusion, neurological damage,
hemorrhage, intestine and bladder injuries, uri-
nary incontinence, constrictor instability, dysuria,
and infection and vaginal erosion caused by the
mesh, in addition to phlebothrombosis and pul-
monary embolism that can generally occur after
major surgery.17 In particular, Podratz et al.18 and
Kohlie et al.19 reported prevalences of vaginal
erosion after surgery using mesh after hysterec-
tomy of 4% and 8%, respectively.
We observed postoperative intestinal occlusion,
hemorrhage, detrusor instability, constipation, ur-
gent urination, frequent urination, urinary incon-
tinence, and vaginal erosion. However, we did
not observe principal complications of pulmonary
embolism, phlebothrombosis, or neurological
damage. Vaginal erosion was found in 3 cases,
and all of these cases were included in group A.
Postoperative adverse reactions were acute
symptoms but these were not significantly dif-
ferent between groups, except for group A, which
showed the highest rate of postoperative fever
and vaginal erosion as both chronic complica-
tions.
Uteropexy is indicated in cases where a young
woman desires a future baby and preservative
treatment for pelvic organ prolapse has failed, or
in cases with a congenital deformation, or when
a patient wishes to preserve the uterus. More-
over, uteropexy is a simpler method than colpo-
plasty after hysterectomy, and has the advantages
of reducing the bleeding, operation time, and
admission days. Although patient numbers were
small, Constnatini et al. reported that patients
were similarly satisfied with uteropexy in com-
parison with the colpoplasty after hysterectomy.2
Banu et al. also reported that uteropexy per-
formed on young women did not induce any
postoperative complications or recurrence, and
did not cause any problems in terms of future
pregnancy.20 Based on our results of uteropexy
versus existing colpoplasty after hysterectomy,
intraoperative bleeding was not considerably
different, but the operation time was significantly
shorter. Moreover, admission days tended to be
reduced, as were postoperative adverse reactions.
In particularly, the uteropexy did not cause
vaginal erosion, which can be occur after mesh
use in colpoplasty after hysterectomy.
The current study has some limitations in
terms of postoperative and side effects compari-
sons, because to the small case numbers, the
short follow-up period, and the predominance of
stage IV patients in group A. However, this is the
first study in Korea to observe the effects and
side effects of pelvic reconstruction followed by
hysterectomy. In comparison with other studies,
this study shows the better surgical effects
including better stage improvement. In addition,
the present study showed fewer complications
and side effects than other studies, no recurrence
or principal complications such as phlebothrom-
bosis or pulmonary embolism or neurological
damage that can be shown after the big surgery.
In conclusion, it is necessary to consider a
patient's uterine size, uterine disease, age, ex-
pectation of pregnancy, and selection for what.
Uteropexy can be considered as an effective sur-
gical method to treat pelvic organ prolapse
patients, and shows fewer postoperative compli-
cations and side effects, and shorter operation
times and admission days than the colpoplasty
after hysterectomy. However, pelvic organ pro-
lapse can recur after several years despite surgi-
cal correction, and therefore, further long-term
follow-up is essential. Moreover, this would con-
firm the effectiveness of uteropexy.
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